These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 18208796)

  • 1. Prognostic factors in cancer of unknown primary site.
    Muñoz A; Fuente N; Rubio I; Ferreiro J; Martínez-Bueno A; López-Vivanco G
    Clin Transl Oncol; 2008 Jan; 10(1):64-5. PubMed ID: 18208796
    [No Abstract]   [Full Text] [Related]  

  • 2. New prognostic index to predict survival in patients with cancer of unknown primary site with unfavourable prognosis.
    Trivanović D; Petkovic M; Stimac D
    Clin Oncol (R Coll Radiol); 2009 Feb; 21(1):43-8. PubMed ID: 18976894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low serum albumin levels and liver metastasis are powerful prognostic markers for survival in patients with carcinomas of unknown primary site.
    Trivanovic D; Petkovic M; Stimac D
    Cancer; 2007 Jun; 109(12):2623-4; author reply 2624. PubMed ID: 17487858
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer of unknown primary patients with midline nodal distribution: midway between poor and favourable prognosis?
    Pentheroudakis G; Stoyianni A; Pavlidis N
    Cancer Treat Rev; 2011 Apr; 37(2):120-6. PubMed ID: 20673701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnosis and therapy of tumors from an unknown primary site].
    Novik AV; Moiseenko VM
    Vopr Onkol; 2004; 50(3):271-8. PubMed ID: 15318700
    [No Abstract]   [Full Text] [Related]  

  • 6. Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary site.
    van der Gaast A; Verweij J; Planting AS; Hop WC; Stoter G
    J Clin Oncol; 1995 Jul; 13(7):1720-5. PubMed ID: 7541451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoma of unknown primary site: development in a single institution of a prognostic model based on clinical and serum variables.
    Ponce Lorenzo J; Segura Huerta A; Díaz Beveridge R; Giménez Ortiz A; Aparisi Aparisi F; Fleitas Kanonnikoff T; Richart Aznar P; de la Cueva Sapiña H; Montalar Salcedo J
    Clin Transl Oncol; 2007 Jul; 9(7):452-8. PubMed ID: 17652059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A long survival of a patient with brain metastasis of unknown site of the primary tumor.
    Ben Kridis W; Sghaier S; Toumi N; Boudawara Z; Khanfir A; Daoud J; Frikha M
    Exp Oncol; 2018 Mar; 40(1):85-87. PubMed ID: 29600979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer of unknown primary. A retrospective study based on 109 patients.
    Maiche AG
    Am J Clin Oncol; 1993 Feb; 16(1):26-9. PubMed ID: 8424399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver metastases from adenocarcinomas of unknown primary site: management and prognosis in 68 consecutive patients.
    Algin E; Ozet A; Gumusay O; Yilmaz G; Buyukberber S; Coskun U; Baykara M; Cetin B; Yıldız R; Benekli M
    Wien Klin Wochenschr; 2016 Jan; 128(1-2):42-7. PubMed ID: 26373751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the unknown in cancer of unknown primary: which way is the right way?
    Pentheroudakis G; Pavlidis N
    Ann Oncol; 2010 Jun; 21(6):1143-1144. PubMed ID: 20089568
    [No Abstract]   [Full Text] [Related]  

  • 12. Individual life expectancy estimation using validated prognostic scores for patients with cancer of unknown primary.
    Ferté C; Penel N; Bonneterre J; Adenis A
    Oncology; 2010; 78(2):87-93. PubMed ID: 20357516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective Analysis of Survival in Patients with Brain Metastases from an Unknown Primary Tumor.
    Cirak M; Guclu DG; Akar E; Kazanci MH; Tural D
    Turk Neurosurg; 2020; 30(6):932-936. PubMed ID: 33216341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Malignant neoplasms with secondary, unspecified or unknown site--significance for cause of death statistics].
    Neumann G
    Offentl Gesundheitswes; 1988 Jan; 50(1):13-9. PubMed ID: 2964572
    [No Abstract]   [Full Text] [Related]  

  • 15. Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy.
    Kodaira M; Takahashi S; Yamada S; Ueda K; Mishima Y; Takeuchi K; Yamamoto N; Ishikawa Y; Yokoyama M; Saotome T; Terui Y; Hatake K
    Ann Oncol; 2010 Jun; 21(6):1163-1167. PubMed ID: 20019088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-center management of 136 patients with cancer of unknown primary site (CUP syndrome) over a period of 10 years.
    Thöm I; Rogers C; Andritzky B; Witzel I; Schuch G; Hossfeld DK; Bokemeyer C; Laack E
    Onkologie; 2009 Dec; 32(12):741-6. PubMed ID: 20016235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site.
    Culine S; Kramar A; Saghatchian M; Bugat R; Lesimple T; Lortholary A; Merrouche Y; Laplanche A; Fizazi K;
    J Clin Oncol; 2002 Dec; 20(24):4679-83. PubMed ID: 12488413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The challenges of understanding cancer of unknown primary.
    Hemminki K; Riihimäki M; Sundquist K; Hemminki A
    Int J Cancer; 2013 Sep; 133(5):1268-9. PubMed ID: 23400909
    [No Abstract]   [Full Text] [Related]  

  • 19. The challenge of attributing causality in cancer of unknown primary.
    Vajdic CM; Wyld L; Symons JN
    Int J Cancer; 2013 Sep; 133(5):1266-7. PubMed ID: 23400944
    [No Abstract]   [Full Text] [Related]  

  • 20. [Prognostic and predictive factors of patients with cancer of unknown origin treated with a paclitaxel-based chemotherapy].
    Muñoz A; Fuente N; Barceló R; Rubio I; Ferreiro J; López Vivanco G
    Med Clin (Barc); 2004 Feb; 122(6):216-8. PubMed ID: 15012889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.